Company Profile Abviva, Inc. is a publicly traded biomedical company established to develop and commercialize diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer.
Abviva intends to build a fully-integrated diagnostic and therapeutic business that is sustained by future revenues from products and services the company develops; to commercialize the Mammastatin Serum Assay through our wholly owned subsidiary laboratory; and, to develop one or more breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institutions world wide.
Exchange: OTC Bulletin Board (www.otcbb.com)
|